Bangladesh vs Nepal: Treatment success rate for patients treated for MDR-TB
Bangladesh
78.0%
in 2022
Nepal
77.0%
in 2022
Bangladesh rank
59th
Nepal rank
61st
Treatment success rate for patients treated for MDR-TB over time
- Bangladesh
- Nepal
How they compare
Bangladesh currently reports 78.0% against 77.0% in Nepal, a difference of 1.0%.
The two have swapped places 6 times across 16 shared years of data; in 2007 it was Bangladesh ahead.
Bangladesh ranks 59th and Nepal ranks 61st of 163 countries.
Across the 3 decades both report, Bangladesh averaged higher in 2 and Nepal in 1.
Head to head by decade
| Decade | Bangladesh | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.0% | 69.7% | 6.3% | Bangladesh |
| 2010s | 74.1% | 72.0% | 2.1% | Bangladesh |
| 2020s | 76.0% | 76.3% | 0.3% | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Bangladesh or Nepal?
- Bangladesh, at 78.0% against 77.0% in Nepal as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Bangladesh and Nepal?
- 1.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Nepal?
- 16 years are reported by both, from 2007 to 2022.
- How do Bangladesh and Nepal rank globally for treatment success rate for patients treated for mdr-tb?
- Bangladesh ranks 59th and Nepal ranks 61st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.